Applied Genetic Technologies (AGTC) Posts Q4 Loss of 48c/Share

Applied Genetic Technologies (NASDAQ: AGTC) reported Q4 EPS of ($0.48), $0.07 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $713 thousand versus the consensus estimate of $630 thousand.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c